EKF Diagnostics (LON:EKF - Get Free Report) issued its quarterly earnings results on Tuesday. The company reported GBX 1.38 ($0.02) earnings per share for the quarter, Digital Look Earnings reports. EKF Diagnostics had a return on equity of 7.03% and a net margin of 9.37%.
EKF Diagnostics Stock Up 3.3 %
Shares of EKF stock traded up GBX 0.70 ($0.01) during trading hours on Friday, reaching GBX 21.90 ($0.28). 3,265,639 shares of the stock were exchanged, compared to its average volume of 559,205. EKF Diagnostics has a 12-month low of GBX 18.40 ($0.24) and a 12-month high of GBX 33.80 ($0.44). The business's fifty day moving average is GBX 23.04 and its two-hundred day moving average is GBX 25.76. The company has a debt-to-equity ratio of 0.34, a current ratio of 4.60 and a quick ratio of 1.77. The firm has a market capitalization of £97.34 million, a P/E ratio of 20.38 and a beta of 0.57.
Insiders Place Their Bets
In other EKF Diagnostics news, insider Gavin T. Jones purchased 50,000 shares of the business's stock in a transaction on Tuesday, March 25th. The shares were bought at an average cost of GBX 22 ($0.28) per share, for a total transaction of £11,000 ($14,237.64). 5.24% of the stock is currently owned by company insiders.
EKF Diagnostics Company Profile
(
Get Free Report)
EKF is an AIM-listed global diagnostics business focussed on:
● Point-of-Care analysers in the key areas of Hematology and Diabetes
● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.
EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.
See Also
Before you consider EKF Diagnostics, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and EKF Diagnostics wasn't on the list.
While EKF Diagnostics currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
